Elanco Revenue and Competitors
Estimated Revenue & Valuation
- Elanco's estimated annual revenue is currently $4.8B per year.
- Elanco's estimated revenue per employee is $549,690
- Elanco's total funding is $2.9M.
Employee Data
- Elanco has 8714 Employees.
- Elanco grew their employee count by 4% last year.
Elanco's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Staff to CEO | Reveal Email/Phone |
2 | CFO Canada and Aqua | Reveal Email/Phone |
3 | CFO Mexico | Reveal Email/Phone |
4 | Executive Director Sales- ECommerce | Reveal Email/Phone |
5 | Chief Staff | Reveal Email/Phone |
6 | Head Key Accounts and Aqua Business | Reveal Email/Phone |
7 | Head Sales Pet Health Veterinary ELANCO | Reveal Email/Phone |
8 | Head Sales (Pet Health) | Reveal Email/Phone |
9 | Head Order to Cash | Reveal Email/Phone |
10 | Head Production | Reveal Email/Phone |
Elanco Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7620M | 11638 | 6% | $40M | $97.5B |
What Is Elanco?
Elanco has helped shape the animal health industry around the world. We introduced our first antibiotic for veterinary use only in 1953. Since then, Elanco has brought more than 35 agricultural and animal health products to the global marketplace, including food industry products such as antibacterials, parasiticides, anticoccidials, productivity enhancers and feed additives, as well as pet medicines.
keywords:N/A
$2.9M
Total Funding
8714
Number of Employees
$4.8B
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Elanco News
US synthetic biology company Ginkgo Bioworks and Elanco Animal Health Inc are launching a new business targeting unmet needs in pet and...
Elanco's $6.9 billion purchase of German-based Bayer Animal Health in 2020 vaulted the company to the second-largest independent animal health...
The global headquarters project was catalyzed by Elanco's $7.6 billion acquisition of Bayer Animal Health business in 2019, Elanco CEO Jeffrey...
Posted By: Sarah Morehouse GREENFIELD, Ind. (July 19, 2021) Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced that the FDA has granted full approval of Tanovea for the treatment of lymphoma in dogs, making this the first conditionally approved new animal drug for dogs that has eve ...
Post by: Jared Skok First external organization to contribute to RestaurAmazônia Project combining cocoa cultivation with cattle raising in the Amazon GREENFIELD, Ind. (June 30, 2021) - Today,the Elanco Foundation announces a partnership with the JBS Fund for the Amazon (The Fund) to jointly s ...